Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Century Therapeutics (IPSC) Asset Utilization Ratio (2022 - 2025)

Century Therapeutics (IPSC) has disclosed Asset Utilization Ratio for 4 consecutive years, with 0.43 as the latest value for Q3 2025.

  • On a quarterly basis, Asset Utilization Ratio rose 6318.98% to 0.43 in Q3 2025 year-over-year; TTM through Sep 2025 was 0.43, a 6318.98% increase, with the full-year FY2024 number at 0.02, up 249.87% from a year prior.
  • Asset Utilization Ratio was 0.43 for Q3 2025 at Century Therapeutics, up from 0.38 in the prior quarter.
  • In the past five years, Asset Utilization Ratio ranged from a high of 0.43 in Q3 2025 to a low of 0.0 in Q1 2024.
  • A 4-year average of 0.1 and a median of 0.01 in 2022 define the central range for Asset Utilization Ratio.
  • Peak YoY movement for Asset Utilization Ratio: crashed 68.93% in 2024, then skyrocketed 8793.05% in 2025.
  • Century Therapeutics' Asset Utilization Ratio stood at 0.01 in 2022, then plummeted by 43.4% to 0.01 in 2023, then soared by 201.38% to 0.02 in 2024, then surged by 2309.91% to 0.43 in 2025.
  • Per Business Quant, the three most recent readings for IPSC's Asset Utilization Ratio are 0.43 (Q3 2025), 0.38 (Q2 2025), and 0.34 (Q1 2025).